BioAdaptives Inc.
Income Statement
| Line Item | FY2018 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | $166.2K | — | $166.0K | $2.4M | — |
| Operating Income | $-1.7M | — | $-227.3K | $-2.4M | — |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $-247.9K | — | — | — | — |
| Pretax Income | $-1.4M | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | $-1.4M | — | $-227.4K | $-2.6M | — |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | $-0.08 | — | $-0.02 | $-0.21 | — |
| EPS (Diluted) | $-0.08 | — | $-0.02 | $-0.21 | — |
| Shares Outstanding (Basic) | 18.1M | 12.7M | 12.7M | 12.5M | 12.0M |
| Shares Outstanding (Diluted) | 18.1M | 12.7M | 12.7M | 12.5M | 12.0M |
| Dividends Per Share | — | — | — | — | — |